원텍
Financials
Valuation Metrics
원텍's Market Cap is ₩4388B. At end of 2025 it was ₩6919B. Ranked #513 of 2,421 in KR market (top 21%), #196 of 1,640 on KOSDAQ (top 12%), #12 of 96 in Health Care Equipment & Services (top 13%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 438.81B KRW | KR#513/2,421 Sec#12/96 |
| Revenue | 167.35B KRW | KR#1,121/2,421 Sec#17/96 |
| Net Income | 39.99B KRW | KR#488/2,421 Sec#11/96 |
| Total Assets | 278.76B KRW | KR#1,077/2,421 Sec#25/96 |
| Net Assets | 173.02B KRW | KR#1,041/2,421 Sec#27/96 |
| Employees | 228 | KR#1,002/2,421 Sec#30/96 |
| Value | ||
| P/E | 10.97x | KR#867/2,421 Sec#28/96 |
| P/B | 2.54x | KR#2,047/2,421 Sec#75/96 |
| PEG | 37.14x | KR#831/2,421 Sec#33/96 |
| P/S | 2.62x | KR#1,934/2,421 Sec#61/96 |
| EV/EBITDA | 10.37x | KR#633/2,421 Sec#21/96 |
| FCF Yield | 11.38% | KR#559/2,421 Sec#11/96 |
| Profitability | ||
| ROE | 23.11% | KR#126/2,421 Sec#5/96 |
| ROA | 14.34% | KR#129/2,421 Sec#9/96 |
| Op. Margin | 25.19% | KR#94/2,421 Sec#6/96 |
| Revenue Growth | 18.77% | KR#587/2,421 Sec#32/96 |
| Earnings Growth | 0.30% | KR#826/2,421 Sec#33/96 |
| Financial Health | ||
| Debt Ratio | 61.12% | KR#1,109/2,421 Sec#63/96 |
| Total Debt | 31.24B KRW | KR#1,207/2,421 Sec#30/96 |
| FCF | 49.94B KRW | KR#298/2,421 Sec#4/96 |
| Cash | 33.08B KRW | KR#942/2,421 Sec#24/96 |
| Current Ratio | 6.44x | KR#191/2,421 Sec#18/96 |
| Net Debt/EBITDA | -0.04x | KR#599/2,421 Sec#23/96 |
| Dividend | ||
| Div. Yield | 1.02% | KR#1,116/2,421 Sec#35/96 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/96 |
| Performance | ||
| 1Y Return | -51.77% | KR#2,084/2,421 Sec#72/96 |
| 1M Return | 1.65% | KR#1,061/2,421 Sec#29/96 |
| From 52W High | -57.00% | KR#1,743/2,421 Sec#53/96 |
| 1Y MDD | -58.95% | KR#1,411/2,421 Sec#47/96 |
| Trading | ||
| Volume | 352,332 shares | KR#317/2,421 Sec#11/96 |
| Trading Value | 1.75B KRW | KR#586/2,421 Sec#14/96 |
| Foreign Own. | 3.36% | KR#1,184/2,421 Sec#41/96 |
| Per Share | ||
| EPS | 448 KRW | KR#1,035/2,421 Sec#29/96 |
| BPS | 1,938 KRW | KR#2,081/2,421 Sec#69/96 |
Company Info
Established in 1999 as a specialized medical device company, Wontech is headquartered in Yuseong-gu, Daejeon Metropolitan City, having completed a merger with Daishin Balance No. 8 Special Purpose Acquisition Company in 2022. It primarily manufactures and sells skin aesthetics lasers and energy-based medical devices, including Oligio, Picocare, and Lavieen, actively exporting to Asia, Europe, the Middle East, and South America. The company diversifies its product lineup through RF and HIFU technology development and strengthens competitiveness by developing Monopolar RF Oligio.